Physician
Robert Allan Havard, M.D.
According to 2025 Medicare claims, Robert Havard, M.D. (NPI: 1144663493) practices medical oncology in the Salt Lake City-Murray, UT market, with the plurality of this provider's patient population coming from Salt Lake, UT. This provider's primary affiliated billing organization is UTAH CANCER SPECIALISTS PC (NPI: 1619925369; TIN: 870519691) and primary practice location at 84106-1494.
Havard's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 366 traditional Medicare patients, billed 95,758 HCPCS/CPT codes, and received $1,528,500 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 935 prescription claims across 167 beneficiaries totaling $3,245,901 in drug costs, led by Brukinsa (Zanubrutinib). 2021 DME data shows 22 claims. Open Payments data shows 60 records totaling $17,311. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $49,270 to $1,528,500. Similarly, Part D prescription costs have risen steadily, from $17,239 to $3,245,901. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.